The genetic disease, phenylketonuria (PKU), is characterized by a deficiency of the enzyme, phenylalanine 4-hydroxylase (EC 1.14.3.1) (1) (2) (3) (4) . In atypical PKU, or hyperphenylalaninemia, phenylalanine hydroxylation occurs in extracts of hepatic tissue at about 3-5% the rate observed in extracts from normal liver (5) (6) (7) .t By contrast, no phenylalanine 4-hydroxylase activity has been detected in liver tissue from individuals with classical PKU (1) (2) (3) (4) 7) . The most recent of these studies would have detected just under 1% of the activity found in normal liver (7) .
All of these studies were performed with the synthetic pterin cofactor, 2-amino-4-hydroxy-6,7-dimethyltetrahydropterin (dimethyltetrahydropterin). In the presence of the natural cofactor, tetrahydrobiopterin, the Km for L-phenylalanine of phenylalanine 4-hydroxylase from normal human liver is 20-to 40-times lower (Friedman and Kaufman, unpublished observations) than it is in the presence of dimethyltetrahydropterin. With the use of tetrahydrobiopterin and lysolecithin, a phospholipid that stimulates the activity of both rat-liver (9) and human-liver phenylalanine hydroxylases (Friedman and Kaufman, unpublished observation), we have been able to detect, for the first time, very low amounts of phenylalanine hydroxylation in extracts from the hepatic tissue of an individual with classical PKU.
MATERIALS AND METHODS
TPNH, glucose-6-phosphate dehydrogenase (EC 1.1.1.49), and catalase (ED 1.11.1.6) were purchased from BoehringerMannheim Corp. Glucose-6-phosphate was obtained from Calbiochem; DL-o-tyrosine and L-p-tyrosine from SchwarzMann; L-DOPA, DL-m-tyrosine, and lysolecithin from Sigma Chemical Co. 6-Fluorotryptophan, 3-iodotyrosine, p-chloro- phenylalanine, and 2-amino-4-hydroxy-6,7-dimethyl-5,6,7,8-tetrahydropteridine were purchased from Aldrich Chemical Co. Tetrahydrobiopterin was a generous gift from Dr. R. F. Long. Dihydropteridine reductase from sheep liver was purified through the calcium phosphate step (10) . Phenylalanine 4-hydroxylase from rat liver was purified through the Sephadex G-200 step (11) . Bovine-adrenal tyrosine hydroxylase was purified through the substituted Sepharose 4B step (12) .
i1[-4C]Phenylalanine (specific activity 383 Ci/mol) and -['4C]tyrosine (specific activity 410 Ci/mol) were purchased from New England Nuclear Corp. Normal human tissue was a gift from Dr. V. H. Auerbach. A biopsy was also obtained from a patient with well-documented classical PKU (serum phenylalanine greater than 20 mg/100 ml on a regular diet; urinary phenylpyruvate present in large amounts). Both samples were quick-frozen immediately upon removal from the body and stored at -80°until use. Small portions were removed from the still-frozen bulk of liver with a razor blade in a cold room at 20. After homogenization with 5 volumes of 0.12 M KCl, extracts were obtained by centrifugation for 45 min at 30,000 X g. Either the extract or a 0-75% ammonium sulfate fraction of the extract was used in enzyme assays. The PKU extract contained 0.12 mM phenylalanine.
The standard reaction mixture for assay of phenylalanine 4-hydroxylase activity contained the following components (in a total volume of either 0.05 or 0.1 ml): 100 mM potassium phosphate (pH 6.8), 0.2 mM TPNH, 1 mM glucose-6-phosphate, L-[14C]phenylalanine at the concentrations indicated for each experiment, and catalase, dihydropteridine reductase, and glucose-f-phosphate dehydrogenase in excess. Lysolecithin was 1 mM when present; tetrahydrobiopterin concentrations are given in figure and table legends. In the assay for phenylalanine hydroxylation by tyrosine hydroxylase, tetrahydrobiopterin was 0.1 mM. Incubations were for 60 or 90 min at 25'. After deproteinization with trichloroacetic acid, aliquots of the supernatant fractions were analyzed by paper chromatography as described (13) . The two solvents used were: (A) 2-propanol-NH40H-H20 8:1:1 and (B) t-butanol-NH40H-methylethyl ketone-H20 10:3:10:5.
Deproteinized reaction mixtures were also applied to a Beckman 120 B aminoacid analyzer. A 50-cm (resin AA-15) column was used, the temperature was 570, and the flow rate was 33 ml/hr. Sodium citrate buffer, 0.2 M (pH 4.25), was used as the elution buffer. Recovery of all unlabeled amino acids (as measured by absorbance) and of radioactivity applied was at least 95%. For preparation of the sample for incubation with tyrosine hydroxylase, the radioactive fractions recovered from the column of the aminoacid analyzer in the region of the p-tyrosine peak were pooled; sodium citrate was removed from the reaction product by passage of the solution through a small (1-ml bed volume) Dowex-50 (H+ form) column. After the column was washed with 3 ml of water, the radioactivity was eluted with 3 ml of 1 N NH4-OH. Recovery of radioactivity was virtually quantitative. The NH40H was removed by evaporation to dryness.
Protein was determined by either the method of Warburg and Christian (14) or by the Lowry method with the use of bovine-serum albumin as standard (15) .
Phenylalanine in the liver extracts was determined by the method of McCaman and Robins (16) . RESULTS 
AND DISCUSSION
Identification of the reaction product
The first indication that an extract of liver from a patient with classical PKU could catalyze the conversion of L-[14C]-phenylalanine to ['4C]tyrosine in the presence of tetrahydrobiopterin and lysolecithin was obtained with the use of the paper chromatographic assay; deproteinized reaction mixtures showed significant radioactivity (above the background of a boiled-enzyme control) in the region in which p-tyrosine chromatographs (Table 1) . To further characterize the reaction product, it was chromatographed in a different solvent. As Table 1 shows, the RF values for m-tyrosine in both solvents are practically indistinguishable from those for ptyrosine; o-tyrosine, however, has different RF values from its isomers and is still distinguishable from phenylalanine in solvent A. These results clearly rule out o-tyrosine as the reaction product. To determine if the product was p-or mtyrosine, the reaction mixture was subjected to column chromatography on an aminoacid analyzer under conditions reported to separate m-and p-tyrosine (17) . A peak of radioactivity was recovered that cochromatographed with added, unlabeled, p-tyrosine (Fig. 1) . The radioactivity recovered in this peak accounts for more than 90% of the radioactivity (above the control) found in the p-tyrosine region after paper chromatography. m-Tyrosine separates cleanly from p-tyrosine on this column (Fig. 1) ; about 2-4% of the radioactivity that was applied to the column was recovered in the area of the m-tyrosine peak. Therefore, the PKU extract catalyzes the conversion of ['4C]phenylalanine to a mixture of 96% p-['4C]tyrosine and 4% m-tyrosine. This result is similar to a recent finding with rat-liver phenylalanine hydroxylase; in the presence of tetrahydrobiopterin and lysolecithin, highly purified rat-liver phenylalanine hydroxylase hydroxylates phenylalanine in the meta position at 5% the rate which it hydroxylates in the para position (Fisher and Kaufman, unpublished results). Table 2 , experiment A, 1 ,umol of unlabeled m-tyrosine, 0.5 mol of p-tyrosine, and 1 ml of water were added. The samples were adjusted to pH 2.2 with H(:l and were manually applied to an aminoacid analyzer. Fractions were collected each minute, and each contained 0.55 ml. The absorbance at 274 nm and radioactivity of each fraction were determined.
If the major product of the reaction catalyzed by the PKU liver extract is tyrosine, tyrosine hydroxylase should catalyze its conversion to DOPA (dihydroxyphenylalanine). In order to study this possibility, the radioactive product that migrated in the p-tyrosine area on the aminoacid analyzer column was incubated with unlabeled p-tyrosine, tetrahydrobiopterin, and highly purified bovine-adrenal tyrosine hydroxylase (12) . The amount of tyrosine hydroxylase added was sufficient to convert about 85%o of the p-tyrosine to DOPA in 90 min.
After this incubation, the reaction mixture was deproteinized with trichloroacetic acid, and unlabeled DOPA was added (see legend to Fig. 2 ). An aliquot was applied to the aminoacid analyzer. After incubation of the "4C-labeled product with tyrosine hydroxylase, 85%o of the radioactivity cochromatographs with unlabeled DOPA (Fig. 2) . The remaining radioactivity is still found in the p-tyrosine area. We conclude from these results that the major product of the reaction with alanine 4-hydroxylase might be the catalyst for the reaction.
To further characterize the enzyme involved, we studied its activity in the presence and absence of tetrahydrobiopterin and lysolecithin. In the absence of tetrahydrobiopterin, no activity was observed (Table 2A) ; when lysolecithin was omitted, the activity was decreased by 50%. Thus, the enzyme is completely pterin-dependent and can be stimulated by lysolecithin. All three of the known pterin-dependent aromatic aminoacid hydroxylases, phenylalanine 4-hydroxylase, tyrosine hydroxylase (18) , and pineal tryptophan hydroxylase (19) , are capable of converting phenylalanine to p-tyrosine. We, therefore, studied the effects of several inhibitors of these pterin-dependent hydroxylases to determine which hydroxylase is responsible for conversion of phenylalanine to p-tyrosine by the PKU liver. p-Chlorophenylalanine inhibits phenylalanine 4-hydroxylase (20) , tyrosine hydroxylase (20) , and tryptophan hydroxylase (21). 1 mM p-chlorophenylalanine completely inhibits the activity of the liver extract from a patient with classical PKU (Table 2C ). This concentration of p-chlorophenylalanine causes more than 90% inhibition of highly purified rat-liver phenylalanine hydroxylase under similar assay conditions. 3-lodotyrosine, a potent inhibitor of tyrosine hydroxylase (22) at 0.1 mM, led to a 14% decrease in phenylalanine hydroxylation by the PKU extract (Table 2B ). The phenylalanine-hydroxylating activity of bovine-adrenal tyrosine hydroxylase, which had been added to the PKU extract, was inhibited more than 98% by 0.1 mM 3-iodotyrosine (Table 2C) . Rat-liver phenylalanine hydroxylase was not inhibited by 3-iodotyrosine. Therefore, 14% of the phenylalanine hydroxylating activity in PKU liver may be due to tyrosine hydroxylase. 6-Fluorotryptophan, a potent inhibitor of tryptophan hydroxylase (20) , at a concentration of 1 mM, led to a 9% decrease in phenylalanine hydroxylase activity in the PKU extracts (Table  2C) . Purified rat-liver phenylalanine hydroxylase is inhibited to about the same degree; by contrast, partially purified rabbit-brain tryptophan hydroxylase was inhibited more than 50% under similar assay conditions (Kappelman and Friedman, unpublished results).
From these characteristics it is apparent that the enzyme In double-immunodiffusion reactions with an antibody for pure rat-liver phenylalanine hydroxylase, an extract of normal human liver gave a single precipitin line (7) . No crossreacting material to this antibody was found in an extract of the PKU liver. These studies would have detected a protein that is antigenically identical to human-liver phenylalanine hydroxylase at 10%, or more, of the concentration of the hydroxylase in normal human liver (7) . These immunological studies left open the possibility that classical PKU results from a deletion mutation that leads to the complete absence of phenylalanine hydroxylase or a crossreacting protein. Our present studies, which rule out the possibility of a deletion of the enzyme, are compatible with the idea that the hydroxylase activity in classical PKU is due to the presence of either normal hydroxylase at an extremely low concentration or structurally altered hydroxylase with low catalytic activity.
The latter possibility seems more reasonable. We previously demonstrated that the phenylalanine hydroxylase from hyperphenylalaninemic liver is structurally altered (7) . One of the properties in which it differs from the normal enzyme is in its response to lysolecithin; the normal enzyme was stimulated 300-400% by lysolecithin under conditions in which the enzyme from hyperphenylalaninemic liver was stimulated about 100% (6) . Under these same conditions, the enzyme from liver of a patient with classical PKU is stimulated only 100% by lysolecithin (see Table 2A ). In an effort to further characterize the phenylalanine hydroxylase from this liver, we compared its phenylalanine saturation curve to the saturation curve observed with normal human liver.
Phenylalanine hydroxylase from a normal human liver has a Km for phenylalanine of 28 nM when assayed with lysolecithin and tetrahydrobiopterin (Fig. 3a) . This value is similar to the Km for phenylalanine of 39 nM obtained under identical conditions with the phenylalanine hydroxylase from another normal human liver (Friedman and Kaufman, unpublished observations). With both of these normal enzyme samples, 50% inhibition is seen at a phenylalanine concentration of 0.14 mM. In contrast, the PKU phenylalanine hydrox- ylase shows no detectable substrate inhibition even at 0.2 mM phenylalanine (Fig. 3b) . The PKU enzyme has a Km for phenylalanine of 37 nM, which is within the normal range cited above. The data in Figs. 3a and 3b can also be used to calculate the percentage of normal hydroxylase activity seen in the PKU liver. Since the normal sample was from a liver from autopsy, it was necessary to compare its activity to a normal sample taken from biopsy. When the normal autopsy sample was assayed with 0.3 mM dimethyltetrahydropterin and 2 mM phenylalanine, a specific activity of 92 nmol of tyrosine per hr per mg of protein was obtained. This value is comparable to the value of 76 ± 14 nmol of tyrosine per hr per mg of protein found for three normal human liver samples obtained by open biopsy, which were assayed at the same concentration of dimethyltetrahydropterin and phenylalanine (13) . Therefore, this normal autopsy sample can be compared to the PKU biopsy sample. When assayed with lysolecithin and tetrahydrobiopterin, the normal autopsy sample has a Vmax of 56 nmol of tyrosine per hr per mg, whereas the PKU biopsy sample has a Vmax of 0.15 nmol of tyrosine per hr per mg of protein. Thus, this PKU sample has a phenylalanine 4-hydroxylase with a specific activity 0.27% of normal.
The capacity of rat-liver phenylalanine hydroxylase antibody to inhibit human phenylalanine hydroxylase activity was used to further study the relationship of the normal and PKU phenylalanine hydroxylases. The normal human-liver extract 7 91 5 tr was diluted 1/200 to give the same activity in the absence of lysolecithin as the undiluted PKU extract. This diluted normal liver extract was incubated for 3 hr at O0 with four concentrations of antiserum over a 10-fold concentration range, with concentrations above and below the equivalence zone. The antibody maximally inhibited the hydroxylase activity by 63% (relative to a control serum). In contrast, when the undiluted PKU liver extract was incubated with the same four concentrations of the antibody, the maximum inhibition of hydroxylase activity was only 18%. Table 3 shows a summary of the properties of the normal and PKU phenylalanine hydroxylases. The decreased substrate inhibition, decreased stimulation by lysolecithin, and decreased inhibition by antibody observed for PKU hydroxylase relative to normal hydroxylase indicate that in this patient there is structurally altered hydroxylase with very low activity rather than a very low amount of normal enzyme. Therefore, we can conclude that this patient with PKU has a mutation in the gene coding for the structure of phenylalanine hydroxylase.
We recently found that highly purified (95% pure) ratliver phenylalanine hydroxylase contains iron and requires iron for enzymatic activity (23) . To test the possibility that the phenylalanine hydroxylase from the PKU liver has low activity because it is deficient in iron, we incubated the PKU enzyme with 2 mM FeCl2, under conditions (1 mM dithiothreitol) favorable for activation of rat-liver phenylalanine hydroxylase (23) . This procedure increased the PKU hydroxylase activity only 15%, an indication that most of the low PKU enzyme activity is not due to a lack of iron in the enzyme.
A protein that stimulates rat-liver phenylalanine hydroxylase has been found in rat-liver extracts (24) . To determine if some of the low in vivo activity of phenylalanine hydroxylase in PKU is due to an insufficient amount of this stimulator, its content in the PKU extract was compared to the amount of the stimulator in normal human liver. There was nearly the same amount of stimulator protein in the PKU and normal liver extracts (Huang and Kaufman, unpublished results).
These results, together with our previous findings (4), indicate that the lack of phenylalanine hydroxylase activity in individuals with PKU is due to a great decrease in the activity of the phenylalanine hydroxylase enzyme, and not to a deficiency in any of the other essential components (tetrahydrobiopterin, dihydropteridine reductase, and iron) of the system or of the stimulating protein.
It was reported recently that patients with classical PKU have between 1 and 5% of the normal hepatic amounts of phenylalanine hydroxylase (25) . The assay for hydroxylase used by these workers, however, did not involve measurement of the conversion of labeled phenylalanine to labeled tyrosine, and, therefore, could not distinguish between protease-dependent liberation of tyrosine (or tyrosine-containing peptides) from proteins in the crude liver extract and phenylalanine hydroxylase-dependent conversion of phenylalanine to tyrosine. Their observation that "tyrosine formation" in the PKU liver extract was not stimulated by added tetrahydropterin, but in fact was inhibited by the pterin, leaves very little doubt that they were not measuring phenylalanine hydroxylase activity in their PKU liver samples.
Our demonstration of small, but significant, phenylalanine hydroxylase activity in liver from a patient with PKU also opens the possibility of purification of the PKU hydroxylase, since the purification can now be followed by measurement of its catalytic activity. Purification of this PKU enzyme should directly answer the question of whether the low activity is due to a small quantity of normal hydroxylase arising from a regulation mutation or due to a normal or low amount of a structurally altered hydroxylase.
